2 completed, 1 unknown. 1 Not applicable, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 2 | 1 | Unknown 1 |
| Phase 3 | 1 | Completed 1 |
Follow Neurocognitive: new trials by email Literature Review of Neurocognitive trials Research Report on Neurocognitive
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Neurocognitive Training on Chronic Ankle Instability Neurocognitive training group - Chronic Ankle Instability, Balance | Not applicable | Completed | Balikesir University | 28 | 2023-09-06 | 2025-06-04 |
| Neurocognition in NSCLC Patients Treated With Osimertinib or Osimertinib + WBI Osimertinib and whole-brain irradiation, Osimertinib - Neurocognitive | Phase 2 | Unknown | Sun Yat-sen University | 88 | 2021-04-07 | 2021-04-02 |
| Darbepoetin Trial to Improve Red Cell Mass and Neuroprotection in Preterm Infants Darbepoetin, Placebo - Neurocognitive, Neuroprotective | Phase 3 | Completed | NICHD Neonatal Research Network | 650 | 2017-09-20 | 2026-07-01 |
Darbepoetin alfa (1) · Organization and Administration (1) · Saline Solution (1) · osimertinib (1)
Balikesir University (1) · NICHD Neonatal Research Network (1) · Sun Yat-sen University (1)
China (1) · Turkey (Türkiye) (1) · United States (1)
Robin Ohls, MD (1) · Ting Zhang (1)
PMID 10840868, PMID 16935061, PMID 17190537, PMID 17379918, PMID 21509114, PMID 22995264, PMID 24255768, PMID 30747379, PMID 31039674, PMID 32067546, PMID 32310156, PMID 32577737, PMID 33432157, PMID 33756239, PMID 34153635, PMID 35514277, PMID 37596391, PMID 40354084, PMID 41392547